Redo Endoscopic Sleeve Gastroplasty: Technical Aspects and Short-term Outcomes
Overview
Authors
Affiliations
Background: Endoscopic sleeve gastroplasty (ESG) is a restrictive endoscopic bariatric procedure providing promising results. In this short case series, we analyze the technical aspects and short-term outcomes of the redo ESG.
Methods: A retrospective analysis was done on a prospective database of all patients that were selected by a multidisciplinary team that underwent ESG between March 2017 and May 2019. Patients that underwent a redo ESG because of a progressive loss of satiety, weight regain, or insufficient weight loss due to high baseline body mass index were included. Percentage of excess weight loss (%EWL), percentage of total body weight loss (%TBWL), and the Bariatric Analysis and Reporting Outcome System (BAROS) questionnaire were evaluated during follow-up.
Results: A total of 120 ESG procedures were performed with mean %EWL of 44.4% (± 19.5), mean %TBWL of 18.3% (± 6.7), and mean BAROS of 4.5 (± 1.7) at 12 months. Of those, four patients that underwent a redo ESG were identified. A total of three of them had a redo ESG after 12 months from the first ESG, whereas one of them had a redo ESG after 7 months. During the second procedure, old threads were removed with scissors and new stitches were positioned following a triangular pattern and avoiding overlap with the previous stitches. No adverse events were reported during the redo ESG. Six month follow-up was available for three patients, mean %EWL and %TBWL were 44.2% and 20.4%, respectively; BAROS questionnaire mean score was 6.3. One patient had only 1 month follow-up with a mean %EWL and %TBWL of 33.3% and 12.2%, respectively; BAROS questionnaire reported score was 6. All included patients reported excellent satiety feeling after redo ESG.
Conclusions: The redo ESG short-term outcomes are completely satisfying in terms of safety and efficacy. The need to perform a redo ESG should not be considered as a failure of the previous procedure, but it can be considered as a second step of the endoscopic treatment strategy.
Nduma B, Mofor K, Tatang J, Amougou L, Nkeonye S, Chineme P Cureus. 2023; 15(7):e41466.
PMID: 37426405 PMC: 10325692. DOI: 10.7759/cureus.41466.
Per-Oral Plication of (Neo)Esophagus: Technical Feasibility and Early Outcomes.
Hedberg H, Attaar M, McCormack M, Ujiki M J Gastrointest Surg. 2023; 27(8):1531-1538.
PMID: 37052876 PMC: 10100616. DOI: 10.1007/s11605-021-05205-9.
Personalized Approach for Obese Patients Undergoing Endoscopic Sleeve Gastroplasty.
Matteo M, DOria M, Bove V, Carlino G, Pontecorvi V, Raffaelli M J Pers Med. 2021; 11(12).
PMID: 34945770 PMC: 8704248. DOI: 10.3390/jpm11121298.
Bove V, Pontecorvi V, Matteo M, Costamagna G, Boskoski I VideoGIE. 2021; 6(9):410-412.
PMID: 34527839 PMC: 8431246. DOI: 10.1016/j.vgie.2021.05.019.
Endobariatric procedures for obesity: clinical indications and available options.
Goyal H, Kopel J, Perisetti A, Mann R, Ali A, Tharian B Ther Adv Gastrointest Endosc. 2021; 14:2631774520984627.
PMID: 33629061 PMC: 7841245. DOI: 10.1177/2631774520984627.